Leaders in the healthcare sector have voiced strong opposition to the decision to dissolve the Healthcare Infection Control Practices Advisory Committee (HICPAC). While it may not be widely recognized by the general public, this advisory committee plays a central role in safeguarding patients and healthcare personnel, making its dissolution a significant concern for the healthcare industry. The committee was tasked with advising the Centers for Disease Control and Prevention on the necessary standards to prevent infection in various healthcare establishments, including hospitals and outpatient clinics.
The Trump administration’s decision to terminate the HICPAC has prompted severe criticism from numerous leaders in healthcare. Four major organizations in the field of infectious diseases, namely, The Infectious Diseases Society of America, The Society for Healthcare Epidemiology of America, the Association for Professionals in Infection Control and Epidemiology, and the Pediatric Infectious Diseases Society, have jointly requested the CDC to reinstate the HICPAC. They emphasized that the advisory committee has been a central pillar in the nation’s public health infrastructure, providing critical, evidence-based guidance to shape federal healthcare standards and protect patients and healthcare professionals across a broad variety of medical settings.
Experts in infectious diseases pointed out that the timing of the committee’s dissolution was particularly unfortunate, given the increasing threats from emerging pathogens and antimicrobial resistance. They warned against a foreseeable gap in national preparedness and response, which can leave healthcare facilities without timely, expert-driven recommendations.
The abrupt dissolution of the HICPAC, which had provided science-based, nonpartisan guidelines for more than 30 years, can potentially impact the consistency of infection control practices across hospitals and public health professionals. The ongoing revision of the guidelines to prevent the transmission of infectious agents in healthcare settings was another critical task the committee was set to undertake. The last guidelines in this regard were updated in 2007. Without the HICPAC, there is a risk of falling behind in tackling emerging health threats.
Healthcare leaders have also voiced their concerns over the implications of broader healthcare policy changes initiated by the Trump administration, including significant staff cuts at the U.S. Department of Health & Human Services and the proposed withdrawal of federal funding for state and local health agencies. There are concerns that these reforms are undermining the capacity of healthcare organizations and agencies to prepare for potential threats and respond to public health emergencies.